Phase II Trial of ASM8 in Asthma Commences

7th Dec 10

Release Date: 07/12/2010 12:00am

Pharmaxis today announced it had enrolled the first subjects into a Phase II clinical trial evaluating the new asthma drug, ASM8, in patients with allergic asthma.


Read full media release - pdf

Categories: News and Media